Cargando…

Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis

OBJECTIVES: We sought to evaluate the association between obesity and response to anti-tumor necrosis factor-α (TNF) agents, through a systematic review and meta-analysis. METHODS: Through a systematic search through January 24, 2017, we identified randomized controlled trials (RCTs) or observationa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Siddharth, Facciorusso, Antonio, Singh, Abha G., Casteele, Niels Vande, Zarrinpar, Amir, Prokop, Larry J., Grunvald, Eduardo L., Curtis, Jeffrey R., Sandborn, William J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957395/ https://www.ncbi.nlm.nih.gov/pubmed/29771924 http://dx.doi.org/10.1371/journal.pone.0195123

Ejemplares similares

Similar pharmacokinetics of three dosing regimens comprising two oral delayed‐release mesalamine formulations in healthy adult volunteers: Randomised, open‐label, parallel‐group study
por: Vande Casteele, Niels, et al.
Publicado: (2020)

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice
por: Vande Casteele, Niels, et al.
Publicado: (2020)

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn’s disease
por: Holmer, Ariela K., et al.
Publicado: (2020)

Obesogenic and leptogenic medication utilization in people with obesity: Is there a prescription for improvement?
por: Grunvald, Eduardo
Publicado: (2022)

Exposure‐response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease
por: Vande Casteele, N., et al.
Publicado: (2017)

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
por: Paul, Stéphane, et al.
Publicado: (2020)

Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation
por: Marotz, Clarisse A., et al.
Publicado: (2016)

Obesity Is Not Associated With an Increased Risk of Serious Infections in Biologic-Treated Patients With Inflammatory Bowel Diseases
por: Singh, Siddharth, et al.
Publicado: (2021)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: Lefevre, Pavine L C, et al.
Publicado: (2020)

Phentermine–topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report
por: Grunvald, Eduardo, et al.
Publicado: (2022)

The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study
por: Leggett, Cecilia B., et al.
Publicado: (2018)

Comparison of Serum Concentrations of Ustekinumab Obtained by Three Commercial Assays in Patients with Crohn’s Disease
por: Verdon, Christine, et al.
Publicado: (2020)

Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study
por: Curtis, Jeffrey R., et al.
Publicado: (2015)

Effect of Obesogenic Medications on Weight-Loss Outcomes in a Behavioral Weight-Management Program
por: Desalermos, Athanasios, et al.
Publicado: (2019)

Systematic review: Safety of balloon assisted enteroscopy in Crohn’s disease
por: Arulanandan, Ahilan, et al.
Publicado: (2016)

Obesity Hypoventilation Syndrome and Postsurgical Outcomes in a Bariatric Surgery Cohort
por: Raphelson, Janna R., et al.
Publicado: (2022)

Evaluation of tumor necrosis factor-α (TNF-α) levels in plasma and their correlation with periodontal status in obese and non-obese subjects
por: Khanna, Suruchi, et al.
Publicado: (2010)

Addition of Financial Incentives to Mailed Outreach for Promoting Colorectal Cancer Screening: A Systematic Review and Meta-analysis
por: Facciorusso, Antonio, et al.
Publicado: (2021)

Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis
por: Dulai, Parambir S, et al.
Publicado: (2016)

Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases
por: Yarur, Andres J., et al.
Publicado: (2020)

Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome
por: Majumdar, Abha, et al.
Publicado: (2009)

Production of Tumor Necrosis Factor‐α by Alveolar Macrophages of Lung Cancer Patients
por: Okubo, Akio, et al.
Publicado: (1990)

Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
por: Peyrin-Biroulet, Laurent, et al.
Publicado: (2021)

NOTCH2 sensitizes the chondrocyte to the inflammatory response of tumor necrosis factor α
por: Canalis, Ernesto, et al.
Publicado: (2023)

Thyroid Hormone Augmentation for Bipolar Disorder: A Systematic Review
por: Seshadri, Ashok, et al.
Publicado: (2022)

Correction: Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
Publicado: (2018)

Endoscopic management of pancreatic walled-off necrosis
por: Ramai, Daryl, et al.
Publicado: (2023)

Dual Regulation of Myocardin Expression by Tumor Necrosis Factor-α in Vascular Smooth Muscle Cells
por: Singh, Pavneet, et al.
Publicado: (2014)

Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
por: Hiraoka, Sakiko, et al.
Publicado: (2018)

Disaccharide Esters Screened for Inhibition of Tumor Necrosis Factor‐α Release Are New Anti‐cancer Agents
por: Okabe, Sachiko, et al.
Publicado: (1999)

Comparative efficacy of first-line therapeutic interventions for achalasia: a systematic review and network meta-analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020)

The circadian coordination of cell biology
por: Chaix, Amandine, et al.
Publicado: (2016)

Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease
por: Bohm, Matthew, et al.
Publicado: (2020)

Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-α
por: Marquez-Curtis, Leah A., et al.
Publicado: (2012)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Hypoglycemia After Gastric Bypass Successfully Treated With Calcium Channel Blockers: Two Case Reports
por: Ames, Angharad, et al.
Publicado: (2019)

Cloning, expression and characterization of biologically active feline tumour necrosis factor-α
por: Rimstad, Espen, et al.
Publicado: (1995)

Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases
por: Singh, Siddharth, et al.
Publicado: (2022)

Comparative Evaluation of Serum Tumor Necrosis Factor α in Health and Chronic Periodontitis: A Case–Control Study
por: Jain, Prince, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gc3654b1sipivaujr2bec7t94i